Evoke Pharma (EVOK) Misses Q3 EPS by 95c
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Join SI Premium – FREE
Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.94), $0.95 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $2.65 million versus the consensus estimate of $4.1 million.
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
- Innoviz to supply LiDAR sensors for Mobileye's robotaxi platform
- Morgan Stanley Resumes Global Payments (GPN) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
